Crucial role of antibodies to pertactin in Bordetella pertussis immunity

被引:93
作者
Hellwig, SMM
Rodriguez, ME
Berbers, GAM
de Winkel, JGJV
Mooi, FR
机构
[1] Univ Med Ctr, Dept Immunol, Immunotherapy Lab, NL-3508 AB Utrecht, Netherlands
[2] Univ Med Ctr, Eijkman Winkler Inst, NL-3508 AB Utrecht, Netherlands
[3] Genmab, Utrecht, Netherlands
[4] Natl Inst Publ Hlth & Environm, Lab Clin Vaccine Res, Bilthoven, Netherlands
[5] Natl Inst Publ Hlth & Environm, Infect Dis Lab, Bilthoven, Netherlands
[6] La Plata Natl Univ, Ctr Invest & Desarello Fermantac Ind, La Plata, Buenos Aires, Argentina
关键词
D O I
10.1086/377283
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pertussis, a serious infectious disease of the respiratory tract caused by Bordetella pertussis, is reemerging in vaccinated populations. Efforts to curtail this disease are hampered by limited insight into the basis of protective immunity. Opsonophagocytosis was recently found to play a central role in cellular bactericidal activity against B. pertussis. In the present study, we studied the specificity of opsonic antibodies. Anti-pertactin antibodies, but not anti-pertussis toxin, anti-fimbriae, or anti-filamentous hemagglutinin antibodies, were found to be crucial for B. pertussis phagocytosis. These data are consistent with field studies showing that levels of antibodies to pertactin correlate with protection.
引用
收藏
页码:738 / 742
页数:5
相关论文
共 21 条
[1]  
[Anonymous], 1991, PRACTICAL STAT MED R
[2]  
BERBERS G, 1999, 105000001 NAT I HLTH
[3]   Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999 [J].
Cassiday, P ;
Sanden, G ;
Heuvelman, K ;
Mooi, F ;
Bisgard, KM ;
Popovic, T .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1402-1408
[4]   A search for serologic correlates of immunity to Bordetella pertussis cough illnesses [J].
Cherry, JD ;
Gornbein, J ;
Heininger, U ;
Stehr, K .
VACCINE, 1998, 16 (20) :1901-1906
[5]   Reemergence of pertussis in the highly vaccinated population of the Netherlands:: Observations on surveillance data [J].
de Melker, HE ;
Schellekens, JFP ;
Neppelenbroek, SE ;
Mooi, FR ;
Rümke, HC ;
Conyn-van Spaendonck, MAE .
EMERGING INFECTIOUS DISEASES, 2000, 6 (04) :348-357
[6]   Targeting to Fcγ receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis [J].
Hellwig, SMM ;
van Oirschot, HFLM ;
Hazenbos, WLW ;
van Spriel, AB ;
Mooi, FR ;
van de Winkel, JGJ .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (06) :871-879
[7]   Pertussis: Current concepts of pathogenesis and prevention [J].
Hewlett, EL .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (04) :S78-S84
[8]   Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity [J].
King, AJ ;
Berbers, G ;
van Oirschot, HFLM ;
Hoogerhout, P ;
Knipping, K ;
Mooi, FR .
MICROBIOLOGY-SGM, 2001, 147 :2885-2895
[9]   Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children [J].
Mastrantonio, P ;
Spigaglia, P ;
van Oirschot, H ;
van der Heide, HGJ ;
Heuvelman, K ;
Stefanelli, P ;
Mooi, FR .
MICROBIOLOGY-UK, 1999, 145 :2069-2075
[10]  
MEADE BD, 1995, PEDIATRICS, V96, P570